Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 15 Sept 2026 for Inhibrx Biosciences, Inc., €46k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Manhard Kimberly: trading record in brief
All filings by Manhard Kimberly on record concern Inhibrx Biosciences, Inc. In total, 5 filings cover trades dated from 8 September 2026 to 15 September 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 15 September 2026, reports a transaction of €46k in Inhibrx Biosciences, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Manhard Kimberly
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
500 shares@ US$105.05CommonSEC144:0001959173-26-006980
500 shares@ US$110.260.0033% mcap14.8% of flowCommonSEC144:0001959173-26-006953
500 shares@ US$111.7750.0033% mcap17.6% of flowCommonSEC144:0001959173-26-006886
500 shares@ US$115.7950.0034% mcap22.1% of flowCommonSEC144:0001959173-26-006844
500 shares@ US$115.140.0034% mcap28.3% of flowCommonSEC144:0001959173-26-006805
5 of 5 declarations
